These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 574527)

  • 1. [Clinical feature and calcitonin therapy on Paget's disease of bone (author's transl)].
    Dokoh S; Morita R; Yamamoto I; Fukunaga M; Hamanaka D; Torizuka K
    Nihon Seikeigeka Gakkai Zasshi; 1979 Aug; 53(8):937-47. PubMed ID: 574527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation by using radionuclide uptake of bone in Paget's disease of bone: special reference to treatment with calcitonin.
    Dokoh S; Fukunaga M; Yamamoto I; Torizuka K; Morita R
    Radioisotopes; 1988 Jun; 37(6):339-42. PubMed ID: 3212230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gallium scanning in Paget's disease of bone: effect of calcitonin.
    Waxman AD; McKee D; Siemsen JK; Singer FR
    AJR Am J Roentgenol; 1980 Feb; 134(2):303-6. PubMed ID: 6766237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of radiography and radioisotope scanning in the detection of Paget's disease and in the assessment of response to human calcitonin.
    Lavender JP; Evans IM; Arnot R; Bowring S; Doyle FH; Joplin GF; MacIntyre I
    Br J Radiol; 1977 Apr; 50(592):243-50. PubMed ID: 870130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of Paget's disease with synthetic human calcitonin (author's transl)].
    Gerschpacher H; Schindler H
    Wien Klin Wochenschr; 1980 Aug; 92(15):535-8. PubMed ID: 6933743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the treatment of the osteodystrophia deformans (Paget's disease) with synthetic salmon calcitonin (author's transl)].
    Trzenschik K; Schmidt UJ; Abendroth K; Ansorg H; Graner H; Lindenhayn K; Schramm G; Kalbe I
    Z Alternsforsch; 1978; 33(5):441-51. PubMed ID: 570764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human calcitonin in the treatment of symptomatic Paget's disease].
    Mathä R; Kovarik J; Woloszczuk W; Plenk H; Willvonseder R; Böhler N; Seidl G; Höfer R
    Aktuelle Gerontol; 1983 Jan; 13(1):10-4. PubMed ID: 6131616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthetic human calcitonin in Paget's disease of bone and osteoporosis (author's transl)].
    Nuti R; Vattimo A
    Dtsch Med Wochenschr; 1981 Jan; 106(5):149-52. PubMed ID: 6162631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic radionuclide study in Paget's disease before and after (Asu1,7) E-calcitonin treatment.
    Vattimo A; Martini G
    J Nucl Med Allied Sci; 1984; 28(3):217-20. PubMed ID: 6241632
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Paget's disease of bone with salmon calcitonin (author's transl)].
    Kuhlencordt F; Ringe JD; Kruse HP
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1620-3. PubMed ID: 7308002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of scintigraphic and roentgenologic studies in Paget's disease under treatment.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Hosking DJ
    Radiol Clin (Basel); 1976; 45(2-4):292-301. PubMed ID: 821096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term therapy with calcitonin in Paget's diseases (author's transl)].
    Schmidt UJ; Trzenschik K; Abendroth K; Graner H; Ansorg A
    Z Alternsforsch; 1978; 33(2):173-83. PubMed ID: 100975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment.
    Waxman AD; Ducker S; McKee D; Siemsen JK; Singer FR
    Radiology; 1977 Dec; 125(3):761-4. PubMed ID: 928705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
    Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The treatment of Paget's disease using salmon thyrocalcitonin. 8 cases (author's transl)].
    Deplante JP; Daumont A; Bouvier M; Lejeune E
    Nouv Presse Med; 1978 Nov; 7(41):3753-6. PubMed ID: 733525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies of the kinetics of bone concentration of mdp-tc 99m in Paget's disease and various treatment methods].
    de La Rochefoucauld B; Basset JY; Rondier J; Cayla J; Ancri D
    Rev Rhum Mal Osteoartic; 1984 Nov; 51(10):575-9. PubMed ID: 6241965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scintigraphic aspects of the recurrence of treated Paget's disease of bone.
    Vellenga CJ; Pauwels EK; Bijvoet OL; Frijlink WB
    J Nucl Med; 1981 Jun; 22(6):510-7. PubMed ID: 7229723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic human calcitonin in refractory Paget's disease of bone.
    Altman RD; Collins-Yudiskas B
    Arch Intern Med; 1987 Jul; 147(7):1305-8. PubMed ID: 3111398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Paget's disease of the skeleton].
    Ziegler R
    Orthopade; 1988 Sep; 17(5):407-10. PubMed ID: 3054712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.